PL145637B1 - Method of obtaining novel aminomethylopyrrolidinones - Google Patents

Method of obtaining novel aminomethylopyrrolidinones Download PDF

Info

Publication number
PL145637B1
PL145637B1 PL1984253280A PL25328084A PL145637B1 PL 145637 B1 PL145637 B1 PL 145637B1 PL 1984253280 A PL1984253280 A PL 1984253280A PL 25328084 A PL25328084 A PL 25328084A PL 145637 B1 PL145637 B1 PL 145637B1
Authority
PL
Poland
Prior art keywords
wzdr
group
general formula
compound
addition salts
Prior art date
Application number
PL1984253280A
Other languages
English (en)
Polish (pl)
Other versions
PL253280A1 (en
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of PL253280A1 publication Critical patent/PL253280A1/xx
Publication of PL145637B1 publication Critical patent/PL145637B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
PL1984253280A 1983-10-04 1984-10-03 Method of obtaining novel aminomethylopyrrolidinones PL145637B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833336024 DE3336024A1 (de) 1983-10-04 1983-10-04 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel

Publications (2)

Publication Number Publication Date
PL253280A1 PL253280A1 (en) 1986-02-11
PL145637B1 true PL145637B1 (en) 1988-10-31

Family

ID=6210932

Family Applications (2)

Application Number Title Priority Date Filing Date
PL1984253280A PL145637B1 (en) 1983-10-04 1984-10-03 Method of obtaining novel aminomethylopyrrolidinones
PL1984249852A PL145630B1 (en) 1983-10-04 1984-10-03 Method of obtaining novel aminomethylpyrrolidinones

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL1984249852A PL145630B1 (en) 1983-10-04 1984-10-03 Method of obtaining novel aminomethylpyrrolidinones

Country Status (27)

Country Link
US (4) US4767759A (ja)
EP (1) EP0136658B1 (ja)
JP (2) JPS6094959A (ja)
KR (1) KR910007882B1 (ja)
AR (1) AR243503A1 (ja)
AU (1) AU565839B2 (ja)
CA (1) CA1242193A (ja)
CS (2) CS244148B2 (ja)
DD (1) DD227963A5 (ja)
DE (2) DE3336024A1 (ja)
DK (1) DK164049C (ja)
ES (3) ES8505652A1 (ja)
FI (1) FI78464C (ja)
GR (1) GR80546B (ja)
HK (1) HK75892A (ja)
HU (1) HU193229B (ja)
IE (1) IE58155B1 (ja)
IL (1) IL73125A (ja)
NO (1) NO165239C (ja)
NZ (1) NZ209759A (ja)
PH (1) PH23764A (ja)
PL (2) PL145637B1 (ja)
PT (1) PT79306B (ja)
SG (1) SG44192G (ja)
SU (2) SU1373318A3 (ja)
YU (2) YU43858B (ja)
ZA (1) ZA847755B (ja)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel
DE3634220A1 (de) * 1986-10-08 1988-04-14 Boehringer Ingelheim Kg Verwendung von 1-benzyl-aminoalkyl-pyrrolidinonen als antidepressiva
DE3706399A1 (de) * 1987-02-27 1988-09-08 Boehringer Ingelheim Kg Mittel mit antidepressiver wirkung
WO1988009330A1 (en) * 1987-05-20 1988-12-01 Zambon Group S.P.A. Isoxazoles with nootropic activity
US4772601A (en) * 1988-01-25 1988-09-20 Hoechst-Roussel Pharmaceuticals, Inc. 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use
ES2043943T3 (es) * 1988-05-20 1994-01-01 Zambon Spa Procedimiento para la preparacion de compuestos con actividad analgesica central.
IL93051A0 (en) * 1989-01-17 1990-11-05 Hoffmann La Roche ((5-oxo-2-pyrrolidinyl)methyl)cyclohexaneacetamides,their preparation and pharmaceutical compositions containing them
IT1231477B (it) * 1989-07-12 1991-12-07 Sigma Tau Ind Farmaceuti (pirrolidin-2-one-1-il) acetammidi quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
US5066663A (en) * 1990-05-21 1991-11-19 Warner-Lambert Company Substituted-hetero-cyclopentanones and cyclopentenones and derivatives thereof acting at muscarinic receptors
JPH083023Y2 (ja) * 1991-05-21 1996-01-29 株式会社四国総合研究所 太陽電池モジュール用架台
US5538985A (en) * 1994-01-27 1996-07-23 Mitsui Toatsu Chemicals, Inc. Pyrrolidinone derivatives
US6001835A (en) * 1996-04-03 1999-12-14 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
EP0891360A4 (en) * 1996-04-03 2002-05-15 Merck & Co Inc FARNESYL PROTEIN TRANSFERASE INHIBITORS
EP0909258A1 (en) * 1996-06-21 1999-04-21 Syntroleum Corporation Synthesis gas production system and method
PE17599A1 (es) 1996-07-09 1999-02-22 Syntroleum Corp Procedimiento para convertir gases a liquidos
US5969138A (en) * 1996-11-01 1999-10-19 Mitsui Chemicals, Inc. Pyrrolidinone derivatives
US5950732A (en) * 1997-04-02 1999-09-14 Syntroleum Corporation System and method for hydrate recovery
AU9690298A (en) 1997-10-10 1999-05-03 Syntroleum Corporation System and method for converting light hydrocarbons to heavier hydrocarbons withseparation of water into oxygen and hydrogen
US6362201B1 (en) 1999-03-02 2002-03-26 Merck & Co., Inc. 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity
AU3386400A (en) * 1999-03-02 2000-09-21 Merck & Co., Inc. 3-alkyl substituted pyrrolidine modulators of chemokine receptor activity
US6372764B1 (en) 1999-03-02 2002-04-16 Merck & Co., Inc. Pyrrolidine modulators of chemokine receptor activity
US6794417B2 (en) 2002-06-19 2004-09-21 Syntroleum Corporation System and method for treatment of water and disposal of contaminants produced by converting lighter hydrocarbons into heavier hydrocarbon
PL1664036T3 (pl) * 2003-09-03 2012-04-30 Pfizer Związki benzimidazolonu wykazujące działanie agonistyczne względem receptora 5-ht4
KR100875558B1 (ko) 2004-06-15 2008-12-23 화이자 인코포레이티드 벤즈이미다졸론 카복실산 유도체
GR1004905B (el) * 2004-07-14 2005-05-27 Ε.Ι.Ε. (Εθνικο Ιδρυμα Ερευνων) Καινοτομα αντιυπερτασικα προιοντα
FR2940609B1 (fr) * 2008-12-30 2011-05-06 Oreal Association de monosaccharides et d'agents desquamants et son utilisation en cosmetique

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133082A (en) * 1960-06-09 1964-05-12 Mead Johnson & Co 1-substituted-3-pyrrolidylmethylamines
NL295221A (ja) * 1962-07-13
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
BE791606A (fr) * 1972-07-10 1973-03-16 Pilot Pen Co Ltd Procede et appareil pour aspirer et soulever la feuille la plussuperieure d'une pile de feuilles de ce type
JPS5244559A (en) * 1975-10-06 1977-04-07 Ise Electronics Corp Fluorescent display tube with luminescent diode
JPS5346966A (en) * 1976-10-06 1978-04-27 Teijin Ltd Lactamamines and their preparation
JPS5344559A (en) * 1976-10-06 1978-04-21 Teijin Ltd New urethanes and their preparation
FR2387218A1 (fr) * 1977-04-15 1978-11-10 Ile De France Nouveaux n-(1'-ethyl 2'-oxo 5'-pyrrolidinyl methyl) benzamides, leurs procedes de preparation et leur application comme modificateurs du comportement
AU518986B2 (en) * 1977-10-11 1981-10-29 Takeda Chemical Industries Ltd. Lactams
CU21107A3 (es) * 1978-02-10 1988-02-01 Hoffmann La Roche Pyrrolidines derivatives
CA1115212A (en) * 1978-02-10 1981-12-29 Emilio Kyburz Pyrrolidine derivatives
DE2924011C2 (de) * 1979-06-13 1982-04-08 A. Nattermann & Cie GmbH, 5000 Köln Pyrrolidin-(2)-on-(1)-ylessigsäure-2,6,-dimethylanilid, Verfahren zur Herstellung und Arzneimittel, welche diese Verbindung enthalten
DE2923975A1 (de) * 1979-06-13 1980-12-18 Nattermann A & Cie Pyrrolidinone, verfahren zu deren herstellung und diese enthaltende arzneimittel
CH657527A5 (de) * 1980-02-13 1986-09-15 Ciba Geigy Ag Verwendung von zentralnervoes-wirksamen verbindungen in einem mittel, welches zur verhinderung oder linderung von nebenwirkungen bestimmt ist.
CH646149A5 (de) * 1981-02-05 1984-11-15 Hoffmann La Roche Pyrrolidin-derivat.
EP0089900B1 (en) * 1982-03-24 1985-12-27 Prodes S.A. New n-((2-oxo-1-pyrrolidinyl)acetyl)piperazines, the methods of producing such new compounds and their salts as well as pharmaceutical preparations for therapeutic use containing these compounds or salts
FR2549053B1 (fr) * 1983-07-12 1985-12-27 Sanofi Sa Nouveaux derives de la pyrrolidine actifs sur le systeme nerveux central, leur procede de preparation, les medicaments en contenant
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel

Also Published As

Publication number Publication date
ES536469A0 (es) 1985-06-01
YU199086A (en) 1987-10-31
ES8601877A1 (es) 1985-11-16
JPH04261152A (ja) 1992-09-17
AU565839B2 (en) 1987-10-01
AU3383484A (en) 1985-04-18
DK474684D0 (da) 1984-10-03
ES8601878A1 (es) 1985-11-16
YU169684A (en) 1987-10-31
NO165239C (no) 1991-01-16
IE842519L (en) 1985-04-04
CS153784A2 (en) 1985-08-15
IL73125A0 (en) 1984-12-31
IE58155B1 (en) 1993-07-14
FI78464C (fi) 1989-08-10
KR850003393A (ko) 1985-06-17
US4996224A (en) 1991-02-26
CS244148B2 (en) 1986-07-17
JPH046684B2 (ja) 1992-02-06
IL73125A (en) 1988-10-31
ES8505652A1 (es) 1985-06-01
PL249852A1 (en) 1985-09-10
GR80546B (en) 1985-02-05
ES539884A0 (es) 1985-11-16
FI843856L (fi) 1985-04-05
HU193229B (en) 1987-08-28
SG44192G (en) 1992-09-04
DE3477922D1 (en) 1989-06-01
EP0136658A3 (ja) 1985-06-05
AR243503A1 (es) 1993-08-31
ES539883A0 (es) 1985-11-16
FI78464B (fi) 1989-04-28
YU43858B (en) 1989-12-31
YU43901B (en) 1989-12-31
US4767759A (en) 1988-08-30
PL145630B1 (en) 1988-10-31
US5073671A (en) 1991-12-17
PH23764A (en) 1989-11-03
ZA847755B (en) 1986-06-25
JPS6094959A (ja) 1985-05-28
FI843856A0 (fi) 1984-10-02
PT79306B (de) 1986-11-13
HUT35641A (en) 1985-07-29
CS410891A3 (en) 1992-08-12
DK474684A (da) 1985-04-05
JPH0739387B2 (ja) 1995-05-01
SU1373318A3 (ru) 1988-02-07
DE3336024A1 (de) 1985-04-18
EP0136658A2 (de) 1985-04-10
PT79306A (de) 1984-11-01
SU1306472A3 (ru) 1987-04-23
NZ209759A (en) 1989-04-26
KR910007882B1 (ko) 1991-10-04
EP0136658B1 (de) 1989-04-26
DK164049C (da) 1992-09-28
CA1242193A (en) 1988-09-20
NO165239B (no) 1990-10-08
DK164049B (da) 1992-05-04
US4833140A (en) 1989-05-23
HK75892A (en) 1992-10-09
DD227963A5 (de) 1985-10-02
PL253280A1 (en) 1986-02-11
NO843979L (no) 1985-04-09

Similar Documents

Publication Publication Date Title
PL145637B1 (en) Method of obtaining novel aminomethylopyrrolidinones
CN101522626A (zh) 作为hdl-胆固醇升高剂的3-吡啶甲酰胺或2-吡嗪甲酰胺衍生物
OA13317A (fr) Dérivés de N-hétérocyclylméthylbenzamides, leur préparation et leur application en thérapeutique.
TW445263B (en) Novel esters of 1,4-disubstituted piperidine derivatives
FR2459240A1 (fr) Aminopiperidines anorexigenes, procede pour leur preparation, intermediaires dans ledit procede et medicaments qui les contiennent
PL144921B1 (en) Method of obtaining novel susbtituted pyrolidinone
FR2533564A1 (fr) Derives de la piperazine presentant une activite anticholinergique et/ou antihistaminique
JPS6026106B2 (ja) アミノアルキリデンアミノ−１，４−ジヒドロピリジン及びその製造法
JPH0225486A (ja) 新規イミダゾキノキサリン化合物、その製造方法並びにその使用
FI78463C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla 1-substituerad-4-hydroximetyl-pyrrolidin-2-oner.
JPS59216877A (ja) 置換フエニル−２−（１ｈ）−ピリミジノン
US3629266A (en) (phenyl piperidino alkyl)3 4-dihydrocarbostyrils
JPH0377867A (ja) 新規オキサゾロピリジン誘導体
JPS59512B2 (ja) ピラゾ−ル −５− オンカゴウブツ ノ セイゾウホウホウ
EP1444234A2 (de) Deuterierte pyrazolopyrimidinone sowie diese verbindungen enthaltende arzneimittel
JPH0327382A (ja) ジヒドロイミダゾキノリノンオキシムスルホン酸誘導体
EP0748806A1 (en) POLYMORPHS B AND C OF 1- 2,4-DICHLORO-BETA-[(7-CHLOROBENZO[b]THIEN-3-YL)METHOXY]PHENETYL]IMIDAZOLE MONONITRATE
US3304304A (en) Quinazolone derivatives
EP0057428A2 (de) Tricyclische Pyrrole, Verfahren zu ihrer Herstellung, ihre Anwendung sowie sie enthaltende Arzneimittel
US3576811A (en) 1-alkyl-1-(beta-piperidino-ethyl)-1,2,3,4- tetrahydronaphthalen-2-ones
US4237132A (en) Morpholinone derivatives and method of use
IE43824B1 (en) Methylthiovalero-and capro-phenone oxime derivatives
FR2877005A1 (fr) Nouveaux derives d'arylpiperazine
US4379926A (en) 1,4,5,6-Tetrahydropyrimidine derivatives
US3300497A (en) 2-aryl-2-piperazinylacetophenones